North America Sexually Transmitted Diseases (STD) Testing Market Size, 2027

North America Sexually Transmitted Diseases (STD) Testing Market Size, Share & Industry Trends Analysis Report By Disease Type, By the Location of Testing, By Country, Historical Data and Growth Forecast, 2021 - 2027

Published Date: February-2022 | Number of Pages: 85 | Format: PDF | Report ID: KBV-16714

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
1.4.2 North America Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
1.4.3 North America Sexually Transmitted Diseases (STD) Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct – 2021, Dec) Leading Players

Chapter 4. North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type
4.1 North America Chlamydia Market by Country
4.2 North America Herpes simplex virus Market by Country
4.3 North America Gonorrhea Market by Country
4.4 North America Syphilis Market by Country
4.5 North America Human papillomavirus (HPV) Market by Country
4.6 North America Other Disease Market by Country

Chapter 5. North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
5.1 North America Laboratory Testing Market by Country
5.2 North America Point of care (POC) Testing Market by Country

Chapter 6. North America Sexually Transmitted Diseases (STD) Testing Market by Country
6.1 US Sexually Transmitted Diseases (STD) Testing Market
6.1.1 US Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.2 US Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 Canada Sexually Transmitted Diseases (STD) Testing Market
6.2.1 Canada Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.2 Canada Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 Mexico Sexually Transmitted Diseases (STD) Testing Market
6.3.1 Mexico Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.2 Mexico Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 Rest of North America Sexually Transmitted Diseases (STD) Testing Market
6.4.1 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.2 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing

Chapter 7. Company Profiles
7.1 BioMérieux S.A.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Danaher Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional & Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
7.10.5.2 Acquisition and Mergers:

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities